Low Therapeutic Threshold for Hepatocyte Replacement in Murine Phenylketonuria
Open Access
- 31 August 2005
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 12 (2), 337-344
- https://doi.org/10.1016/j.ymthe.2005.03.025
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- 878. Correction of Maternal Phenylketonuria Syndrome in the Pahenu2 Missense Mutant Mouse by r-AAV Mediated Gene TherapyMolecular Therapy, 2004
- Long-term correction of hyperphenylalaninemia by AAV-mediated gene transfer leads to behavioral recovery in phenylketonuria miceGene Therapy, 2004
- State-of-the-art 2003 on PKU gene therapyMolecular Genetics and Metabolism, 2003
- Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up1Transplantation, 2003
- Long-Term Therapy with NTBC and Tyrosine-Restricted Diet in a Murine Model of Hereditary Tyrosinemia Type IMolecular Genetics and Metabolism, 2002
- Metabolic engineering as therapy for inborn errors of metabolism – development of mice with phenylalanine hydroxylase expression in muscleGene Therapy, 1998
- Characterization of Mutations at the Mouse Phenylalanine Hydroxylase LocusGenomics, 1997
- Hepatocytes corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type INature Genetics, 1996
- RAG-1-deficient mice have no mature B and T lymphocytesCell, 1992
- Reconstitution of enzymatic activity in hepatocytes of phenylalanine hydroxylase-deficient miceSomatic Cell and Molecular Genetics, 1992